Issue 44, 2025, Issue in Progress

Design, synthesis and evaluation of arylpurine-based sinefungin mimetics as zika virus methyltransferase inhibitors

Abstract

Arylpurine derivatives were designed and synthesized to mimic sinefungin by targeting the SAM/SAH binding site of zika virus (ZIKV) methyltransferase (MTase). These compounds incorporate adenine or 6-methyl-7-deazapurine bases, while the ribose of sinefungin has been replaced by an aniline, linked to its amino acid chain via a CO or a CH2 unit. Compounds 18, 29 and 31 inhibited ZIKV 2′-O-MTase activity. Docking studies showed that compounds 18 and 29 interact with both the purine and amino acid binding sites, effectively mimicking sinefungin. In contrast, compound 31 has its amino acid chain positioned above the ribose binding site. Notably, compound 18 exhibited modest antiviral activity against ZIKV.

Graphical abstract: Design, synthesis and evaluation of arylpurine-based sinefungin mimetics as zika virus methyltransferase inhibitors

Supplementary files

Article information

Article type
Paper
Submitted
24 Jul 2025
Accepted
25 Sep 2025
First published
07 Oct 2025
This article is Open Access
Creative Commons BY license

RSC Adv., 2025,15, 37309-37324

Design, synthesis and evaluation of arylpurine-based sinefungin mimetics as zika virus methyltransferase inhibitors

N. del Río, I. Arribas-Álvarez, J. Orduña, P. Sutto-Ortiz, J. Neyts, S. Kaptein, E. Decroly, E. Priego and M. Pérez-Pérez, RSC Adv., 2025, 15, 37309 DOI: 10.1039/D5RA05362E

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements